Paul Studenic
Affiliated to Research
E-mail: paul.studenic@ki.se
Visiting address: CMM L8:04 Karolinska universitetssjukhuset, 17176 Stockholm
Postal address: K2 Medicin, Solna, K2 Reuma Malmström V, 171 77 Stockholm
About me
- Paul Studenic, specialised in internal medicine and rheumatology, works as
post-doc researcher in the team of Anca Catrina studying outcome measures in
people at-risk for developing RA.
*Paul Studenic *is, as post-doc researcher in Anca Catrina’s group,
addressing the utility and validation of patient reported outcomes in people
at-risk for developing rheumatoid arthritis within the ongoing RISK-RA and
PREVENT-RA studies. He did his medical training at the Medical University of
Vienna in Austria and his PhD under the supervision of Daniel Aletaha on
clinical outcomes, patient perspective and methodological approaches in
rheumatoid arthritis. As specialist for Internal medicine he further trained
in Rheumatology and was strongly engaged in structuring/quality assurance of
patient registries for inflammatory arthritis, Sjögren’s and at-risk
patients in Vienna. Furthermore, he is active in collaborative research and
education within the network of the European League against Rheumatism.
Articles
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(10):1268-1277
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(9):1162-1170
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(3):344-350
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(1):74-80
- Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(1):15-22
- Article: RMD OPEN. 2022;8(2):e002472
- Article: RHEUMATOLOGY. 2022;61(7):2815-2825
- Article: JOURNAL OF TRANSLATIONAL AUTOIMMUNITY. 2022;5:100142
- Article: FRONTIERS IN MEDICINE. 2022;9:824501
- Article: WIENER KLINISCHE WOCHENSCHRIFT. 2021;133(23-24):1255-1264
- Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021;51(5):1108-1112
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(7):884-890
- Article: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2021;13:1759720X211022533
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(11):1423-1431
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(4):445-452
- Article: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2020;12:1759720X20933489
- Article: RHEUMATOLOGY. 2019;58(10):1802-1811
- Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):234
- Article: RHEUMATOLOGY. 2018;57(3):572-577
- Article: FRONTIERS IN IMMUNOLOGY. 2018;9:876
- Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):720-727
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(4):712-715
- Article: RMD OPEN. 2017;3(2):e000514
- Article: RHEUMATOLOGY. 2016;55(1):41-48
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(11):2022-2027
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(10):1702-1705
- Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(9):2814-2823
- Show more
All other publications
- Editorial comment: RMD OPEN. 2024;10(2):e003851
- Review: RMD OPEN. 2023;9(4):e003566
- Letter: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(9):e202
- Letter: RMD OPEN. 2022;8(2):e002576
- Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(4):e56
- Editorial comment: THE LANCET RHEUMATOLOGY. 2022;4(3):E157-E159
- Editorial comment: JOURNAL OF RHEUMATOLOGY. 2022;49(2):123-125
- Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(2):340
- Review: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2022;14:1759720X221105978
- Editorial comment: JOINT BONE SPINE. 2021;88(4):105163
- Review: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(1):57-64
- Editorial comment: RMD OPEN. 2020;6(3):e001034
- Editorial comment: RHEUMATOLOGY. 2020;59(1):9-11
- Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(6):e54
- Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(8):1245-1246
- Review: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2017;47(2):193-198